Association between Clustering of Cardiometabolic Risk Factors and Chronic Kidney Disease: Findings from the China Health and Retirement Longitudinal Study
Empagliflozin's role in reducing ventricular repolarization heterogeneity: Insights into cardiovascular mortality decline from the EMPATHY-HEART trial
The Impact of Metabolic Syndrome Severity on Frailty Progression among Chinese middle and old-aged adults: A Longitudinal Study
Association of triglyceride-glucose index and its related parameters with atherosclerotic cardiovascular disease: evidence from a 15-year follow-up of Kailuan cohort
Dapagliflozin Reduces Systemic Inflammation in Patients with Type 2 Diabetes Without Known Heart Failure
Six-month supplementation with high dose coenzyme Q10 improves liver steatosis, endothelial, vascular and myocardial function in patients with metabolic-dysfunction associated steatotic liver disease: A Randomized Double-blind, Placebo-Controlled Trial
BMI Variability and Cardiovascular Outcomes Within Clinical Trial and Real-World Environments in Type 2 Diabetes: An IMI2 SOPHIA study
Interactions between the gut microbiome, associated metabolites and the manifestation and progression of heart failure with preserved ejection fraction in ZSF1 rats
Impact of acute glycemic variability on short-term outcomes in patients with ST-segment elevation myocardial infarction: a multicenter population-based study
Which Surrogate Insulin Resistance Indices Best Predict Coronary artery disease? a machine learning approach